Biotech bounced back in 2013, says report


Financial services firm EY says in its annual assessment of the global biotechnology sector that the industry is performing strongly, but needs to focus on using its R&D resources more efficiently to ‘unlock value’.

Revenues, R&D spending and companies’ ability to raise capital funding all increased in 2013 compared to 2012. But the report highlights a need for the industry to be smarter about how it spends that cash. Particularly, EY decries the high failure rate of expensive Phase III clinical trials. While this observation will not surprise anyone in the industry, the report draws on case studies from across the industry to suggest some strategies that might improve efficiency.

Chief among these is not skimping on earlier trials, and designing trials to be adaptive, so they can test multiple hypotheses and reach more definitive conclusions. Other recommendations reinforce trends that are already beginning to take hold within the pharmaceutical industry: using biomarker-based diagnostics to target products more effectively at populations where they will have greatest effect, and collaborating early and often, particularly on pre-competitive problems that affect the whole sector.


Related Content

Bounce denotes battery health

31 March 2015 Research

news image

Physical changes as battery discharges correlated with bounce

Sublime Leidenfrost

4 July 2013 Research

news image

Drop water on dry ice and a carbon dioxide layer will keep the water liquid and make it dance on (dry) ice

Most Read

Lawrencium experiment could shake up periodic table

9 April 2015 Research

news image

Measurement of first ionisation energy confirms electronic configuration but opens up an important debate

Super-fast charging aluminium batteries ready to take on lithium

7 April 2015 Research

news image

New battery charges in under a minute and still performs perfectly after being recharged thousands of times

Most Commented

Women twice as likely to be hired for academic posts as men

17 April 2015 News and Analysis

news image

Experiment shows that faculty staff are more likely to pick women for job roles based on hypothetical CVs

Big problems with little particles?

9 April 2015 Feature

news image

There is a risk that poor toxicology studies could start undermining the success of nanomaterials, reports Elinor Hughes